CureVac raised €80M in a Series D+ round in Sep 2012. The company is based in T√ºbingen, Germany. Data as of 6 Aug 2026.
Reported in EUR — no conversion. €80M
No source on record — unverified.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
No investors disclosed for this round.
